Lori A. Blauwet, M.D., studies peripartum cardiomyopathy, cardiac sarcoidosis and prosthetic heart valves.
Dr. Blauwet is primarily involved in clinical research involving retrospective and prospective studies of patients at Mayo Clinic. She also collaborates with other investigators in the United States and internationally.
- Peripartum cardiomyopathy (PPCM)
- Epidemiology of PPCM
- Echocardiographic assessment of patients with PPCM
- Predictors of outcome in patients with PPCM
- Management of patients with PPCM
- Risk of subsequent pregnancy in patients with PPCM
- Cardiac sarcoidosis (CS)
- Establishment of the Mayo Clinic Cardiac Sarcoid Registry
- Biomarkers in CS
- Diagnostic algorithms of patients with suspected CS
- Use of multimodality imaging in diagnosing and treating patients with CS
- Predictors of outcomes in patients with CS
- Sex differences in presentation and outcomes in patients with CS
- Prosthetic heart valves
- Echocardiographic assessment of prosthetic heart valves
- Establishment of normative Doppler-derived hemodynamic data for normal:
- Aortic valve prostheses
- Mitral valve prostheses
- Tricuspid valve prostheses
- Pulmonary valve prostheses
- Designing algorithms to determine prosthetic valve function using echocardiographic parameters
Significance to patient care
There are many knowledge gaps in understanding the pathophysiology, epidemiology, management and outcomes in patients with rare cardiomyopathies, including peripartum cardiomyopathy and cardiac sarcoidosis. Dr. Blauwet's research focuses on investigating meaningful clinical questions in order to impact the diagnosis, treatment and prognosis of patients with peripartum cardiomyopathy and cardiac sarcoidosis.
Dr. Blauwet has published numerous papers and has given numerous presentations on the echocardiographic assessment of prosthetic heart valves in order to enable echocardiographers and clinicians to better determine whether or not a prosthetic heart valve is functioning normally. Her research is enhancing the clinical assessment and decision-making processes for patients with prosthetic heart valves.